The National Institutes of Health last month announced two funding opportunities with potential microRNA components, seeking grant proposals in the areas of acute kidney injury and the genomic basis of neurodevelopment and mental disorders.

Through the first funding opportunity, the NIH aims to support a broad range of research into acute kidney injury, or AKI, in older adults — a population the agency said has seen the fastest increase in incidence of the condition in recent decades.